NCT06353360 2024-08-09
TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Phase 2 Unknown
Clinical Trials
53 trialsNCT05638451 2024-06-05
Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
Zhujiang Hospital
Phase 2 Unknown
NCT05106023 2023-06-07
To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma
Fudan University
Phase 2 Unknown
NCT05885386 2023-06-01
A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL
Peking Union Medical College Hospital
Phase 2 Unknown
NCT02137759 2023-05-06
MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
Emory University
Phase 2 Unknown
NCT05827770 2023-04-25
The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma
Fudan University
Phase 2 Unknown
NCT03359005 2022-11-01
Irinotecan and Temozolomide for Ewing Sarcoma
Peking University People's Hospital
Phase 2 Unknown
NCT05031975 2022-09-02
ERASE-TMZ
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT04514393 2022-04-07
Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
Sun Yat-sen University
Phase 2 Unknown
NCT03932981 2021-09-10
TEMOTRAD01
Assistance Publique - Hôpitaux de Paris
Phase 2 Unknown
NCT04884997 2021-05-13
A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
NCT04674527 2020-12-19
Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown
NCT04583020 2020-11-30
Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04552977 2020-09-17
A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT04450160 2020-06-29
AEO
MetVital, Inc.
Phase 2 Unknown
NCT04397770 2020-05-21
Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT04224441 2020-01-13
RACTAC
Regina Elena Cancer Institute
Phase 2 Unknown
NCT04157478 2019-11-12
Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
People's Hospital of Guangxi Zhuang Autonomous Region
Phase 2 Unknown
NCT03741244 2019-07-23
TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT
The Second Hospital of Hebei Medical University
Phase 2 Unknown
NCT02605811 2019-03-28
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
Guangzhou Medical University
Phase 2 Unknown
NCT02209428 2019-02-21
A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas
Huashan Hospital
Phase 2 Unknown
NCT02672241 2018-10-16
Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT03279601 2017-09-12
Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor
Peking University
Phase 2 Unknown
NCT03204019 2017-06-29
A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor
ChineseAMS
Phase 2 Unknown
NCT03204032 2017-06-29
A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor
ChineseAMS
Phase 2 Unknown
NCT02972320 2016-11-23
Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic
China Medical University, China
Phase 2 Unknown
NCT02928575 2016-10-10
Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 2 Unknown
NCT02681705 2016-08-17
Radiation Therapy and Combination Chemotherapy for Medulloblastoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT02832635 2016-07-14
A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases
Sun Yat-sen University
Phase 2 Unknown
NCT01900951 2016-01-26
Temozolomide as Maintenance Therapy in Small Cell Lung Cancer
Chinese PLA General Hospital
Phase 2 Unknown
NCT02663440 2016-01-26
Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT02133677 2014-05-08
A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases
Far Eastern Memorial Hospital
Phase 2 Unknown
NCT00492687 2014-01-10
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003718 2014-01-06
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00004204 2014-01-06
Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00033709 2014-01-06
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01985451 2013-11-15
Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL）
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT00005054 2013-09-20
Temozolomide in Treating Women With Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00360945 2013-09-17
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01217398 2013-08-26
Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00514397 2013-08-12
Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01735747 2013-03-12
Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT01670890 2012-08-22
Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas
Peking Union Medical College Hospital
Phase 2 Unknown
NCT00503594 2012-07-30
CNSLymphoma
Assistance Publique - Hôpitaux de Paris
Phase 2 Unknown
NCT01124240 2011-07-26
ExCentric
Northern Sydney and Central Coast Area Health Service
Phase 2 Unknown
NCT00643825 2010-07-23
PATSGO
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 2 Unknown
NCT00991250 2010-02-05
SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma
SentoClone AB
Phase 2 Unknown
NCT00660283 2010-01-20
KARE003
Kentuckiana Cancer Institute
Phase 2 Unknown
NCT00660621 2010-01-20
KARE004
Kentuckiana Cancer Institute
Phase 2 Unknown
NCT00875355 2009-08-26
Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown